Clinical trial
A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the SINOMED IAS for the Treatment of Intracranial Aneurysms
NCT06303063 is registered in ClinicalTrials.gov with Sinomed Neurovita Technology Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the SINOMED IAS for the Treatment of Intracranial Aneurysms
- Lead sponsor
- Sinomed Neurovita Technology Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 17, 2024
- Completion date
- November 20, 2025
- Enrollment
- 203 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.